homepage-02 By Posted August 16, 2014 In homepage-022014-08-162014-08-16https://apyxmedical.com/wp-content/uploads/2018/12/apyx-logo-footer_orange-white_150w.pngApyx Medicalhttps://apyxmedical.com/wp-content/uploads/2018/12/apyx-logo-footer_orange-white_150w.png200px200px 0 apyxmedical Recent PostsAPYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024RENUVION NAMED #1 TRUSTED BODY CONTOURING TECHNOLOGY BY DOCTORS*APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION COMPARING THE USE OF RENUVION TO A COMPETING TECHNOLOGY FOLLOWING LIPOSUCTION OR BODY CONTOURING PROCEDURESAPYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK